Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IQE PLC Director's Dealing 2021

Nov 26, 2021

7718_dirs_2021-11-26_48214ecb-c308-4d17-8169-ae71208b1a42.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

IQE plc

Cardiff, UK

26 November 2021

Director/PDMR Shareholding

IQE plc (AIM: IQE, "IQE" or the "Group"), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, was notified on 25 November 2021 that on that date, Mrs Carol Chesney, Senior Independent Director of the Company, and her husband Mr Simon Chesney, each purchased 20,000 ordinary shares of 1 pence each in the Company (“Ordinary Shares”).

This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of the Person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a) Name i)      Mrs Carol Chesney

      ii)      Mr Simon Chesney
2. Reason for the notification
a) Position / status i)      PDMR (Senior Independent Director)

      ii)      Person closely associated with a PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name IQE plc
b) Legal Entity Identifier 213800Y33WHD3ESJJP16
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument Ordinary shares of 1 pence each in the Company



GB0009619924
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s) i)      20,000 Ordinary Shares at 38.0762p per Ordinary Share







      ii)      20,000 Ordinary Shares at 38.0762p per Ordinary Share
d) Aggregated information

-  Aggregated volume
-  Aggregated price
i)      Aggregated volume: 20,000

                              Aggregated price: £7,615.24







                  ii)      Aggregated volume: 20,000

Aggregated price: £7,615.24
e) Date of the transaction(s) 25 November 2021
f) Place of the transaction London Stock Exchange, AIM (AIMX)

Contacts:

IQE plc

+44 (0) 29 2083 9400

Phil Smith

Tim Pullen

Amy Barlow

Peel Hunt LLP (Nomad and Joint Broker)

+44 (0) 20 7418 8900

Edward Knight

Paul Gillam

James Smith

Citigroup Global Markets Limited (Joint Broker)

+44 (0) 20 7986 4000

Christopher Wren

Peter Catterall        

Headland Consultancy (Financial PR)

+ 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Chloe Francklin: +44 (0)78 3497 4624

ABOUT IQE

http://iqep.com

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

  • handset devices
  • global telecoms infrastructure
  • connected devices
  • 3D sensing

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the whole market and is agnostic to the winners and losers at chip and OEM level. By leveraging the Group’s intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with c. 670 employees across nine manufacturing locations in the UK, US, Taiwan and Singapore, and is listed on the AIM Stock Exchange in London.